Almac expands Asia Pacific operations
Global CDMO Almac has expanded its clinical services and technologies capabilities in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and manage global trials from the region. Local teams will design, implement and manage drug supply strategies and efficient technology solutions throughout the life of each study.
Almac’s local teams support studies of all sizes and degrees of complexity, helping sponsors to achieve time-saving efficiencies, reduce costs and improve trial outcomes. Services are augmented by a secure, web-based interface to monitor trial execution anywhere in the world, multi-lingual technical and project teams and an in-house, always available hotline connecting site staff to on-call clinicians and unblinding specialists.
By positioning operational resources within the same time zones as where trials are executed, Almac is able to resolve issues in less than 24 hours, which in turn eliminates communications delays and improves patient care.
Almac is strengthening its Asia Pacific offerings by establishing a new secondary packaging facility in Singapore that will open by the end of 2014. Through this facility, the company will better enable just-in-time supply management and support drug pooling strategies, which further optimize the supply chain, minimize wastage and reduce costs.
“With 15% of all clinical trials conducted in Asia, it’s imperative that we provide localized service and support to our clients,” said Alan Armstrong, CEO, Almac. “We’ve long managed clinical trials on a global basis, but there’s now sufficient critical mass that requires we establish dedicated resources in the region.”